CTXR
NASDAQ
$0.48
Citius Pharmaceuticals Inc (CTXR)
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products. The company is headquartered in Cranford, New Jersey.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $4 (+732.29%)
Market Cap
$12M
P/B Ratio
0.24
Revenue 5Y CAGR
+128.54%
Beta (5Y)
1.42
Price Chart
Valuation
Market Cap$12M
Forward P/E0.32
P/S2.60
P/B0.24
Profitability
Total Revenue (TTM)$5.61M
Gross Profit (TTM)$4.49M
EBITDA-$55M
Operating Margin-1828%
EPS-$2.80
Growth & Risk
EPS 5Y CAGR-20.51%
Revenue 5Y CAGR+128.54%
FCF 5Y CAGR+8.32%
Beta (5Y)1.42
Sharpe Ratio-0.69